EP2977042
OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION
Status:
EP einkaleyfi: Þýðing ekki lögð innEP appl. date:
7.2.2007EP published:
1.1.2020EP application number:
15185071.6
EPO information:
European Patent Register
Max expiry date:
6.2.2027
Title:
OLOPATADINE FORMULATIONS FOR TOPICAL NASAL ADMINISTRATION
Timeline
Today
7.2.2007EP application
1.1.2020EP Publication
Owner
Name:
Novartis AGAddress:
4002 Basel, CH
Inventor
Name:
Singh, Onkar, N.Address:
Arlington, TX Texas 76017, US
Name:
Wall, G., MichaelAddress:
Fort Worth, TX Texas 76109, US
Name:
Jani, RajniAddress:
Fort Worth, TX Texas 76109, US
Name:
Chowhan, Masood A.Address:
Arlington, TX Texas 76016, US
Name:
Han, Wesley, WehsinAddress:
Arlington, TX Texas 76006, US
Classification
Categories:
A61K 9/00, A61K 31/335, A61K 47/02, A61K 47/18, A61K 9/08